Biogen Idec

Biogen Idec is a leading global biotechnology company, listed on the NASDAQ and a constituent of the NASDAQ 100 Index, formed in 2003 through the merger of Biogen (founded in 1978) and IDEC (founded in 1986), which develops medicines for neurological disorders and cancer.